HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mitsuru Adachi Selected Research

nedaplatin

9/2011A feasibility study of zoledronic acid combined with carboplatin/nedaplatin plus paclitaxel in patients with non-small cell lung cancer with bone metastases.
5/2009Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
4/2008Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
2/2008[Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1].
5/2006Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer.
1/2003Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Mitsuru Adachi Research Topics

Disease

37Asthma (Bronchial Asthma)
01/2015 - 03/2002
15Inflammation
01/2010 - 03/2002
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2011 - 01/2003
8Insulin Resistance
03/2008 - 06/2002
7Neoplasms (Cancer)
09/2011 - 08/2004
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2011 - 06/2003
6Coronary Disease (Coronary Heart Disease)
03/2008 - 08/2002
5Lung Neoplasms (Lung Cancer)
09/2011 - 12/2004
5Atherosclerosis
10/2008 - 03/2003
5Hypertension (High Blood Pressure)
01/2008 - 06/2003
5Hypertriglyceridemia
06/2007 - 08/2002
4Chronic Obstructive Pulmonary Disease (COPD)
01/2012 - 11/2004
4Infection
01/2010 - 06/2005
4Dyslipidemias (Dyslipidemia)
03/2008 - 09/2004
4Rheumatoid Arthritis
01/2008 - 01/2003
4Obstructive Sleep Apnea
11/2007 - 03/2003
3Hypersensitivity (Allergy)
09/2014 - 09/2011
3Lung Injury
09/2011 - 01/2008
3Diabetic Nephropathies (Diabetic Nephropathy)
08/2008 - 06/2003
3Chronic Kidney Failure (Chronic Renal Failure)
03/2008 - 04/2007
3Anoxia (Hypoxia)
09/2005 - 03/2003
3Eosinophilia
01/2005 - 03/2002
2Cough
11/2013 - 08/2004
2Food Hypersensitivity (Food Allergy)
05/2013 - 06/2007
2Seasonal Allergic Rhinitis (Hay Fever)
04/2012 - 07/2002
2Dyspnea (Shortness of Breath)
01/2012 - 08/2004
2Neoplasm Metastasis (Metastasis)
09/2011 - 08/2004
2Anemia
02/2010 - 11/2009
2Thrombocytopenia (Thrombopenia)
02/2010 - 11/2009
2Neutropenia
02/2010 - 11/2009
2Cardiovascular Diseases (Cardiovascular Disease)
12/2008 - 12/2004
2Carotid Artery Diseases
12/2008 - 02/2007
2Obesity
12/2008 - 06/2002
2Atherosclerotic Plaque (Atheroma)
10/2008 - 06/2006
2Proteinuria
03/2008 - 06/2003
2Adenocarcinoma
02/2008 - 08/2004
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2008 - 08/2004
2Hypercholesterolemia
06/2007 - 01/2006

Drug/Important Bio-Agent (IBA)

17Adrenal Cortex Hormones (Corticosteroids)IBA
01/2015 - 03/2002
6fluticasone (Cutivate)FDA LinkGeneric
06/2012 - 06/2007
6nedaplatinIBA
09/2011 - 01/2003
6Interleukin-17 (Interleukin 27)IBA
05/2009 - 12/2004
6Insulin (Novolin)FDA Link
01/2008 - 06/2002
5Theophylline (Theon)FDA LinkGeneric
09/2014 - 09/2006
5Carboplatin (JM8)FDA LinkGeneric
09/2011 - 06/2003
5irinotecan (Camptosar)FDA LinkGeneric
06/2011 - 06/2003
5urotensin IIIBA
12/2008 - 10/2005
5Lipoproteins (Lipoprotein)IBA
12/2008 - 01/2002
5FructoseIBA
01/2008 - 06/2002
4HFA 134a (hydrofluoroalkane)IBA
06/2012 - 06/2007
4Beclomethasone (Beclometasone)FDA Link
06/2012 - 06/2007
4anti-IgEIBA
04/2012 - 03/2011
4salmeterol (Serevent)FDA Link
02/2012 - 07/2008
4Paclitaxel (Taxol)FDA LinkGeneric
09/2011 - 02/2008
4Cisplatin (Platino)FDA LinkGeneric
11/2009 - 12/2004
4ApolipoproteinsIBA
10/2008 - 08/2002
4CytokinesIBA
04/2006 - 05/2003
3Aminophylline (Carine)FDA LinkGeneric
09/2014 - 12/2006
3OxygenIBA
09/2014 - 01/2008
3Immunoglobulin E (IgE)IBA
09/2014 - 07/2002
3Leukotriene Receptors (Leukotriene Receptor)IBA
04/2012 - 12/2009
3docetaxel (Taxotere)FDA Link
04/2011 - 07/2007
3Phosphopyruvate Hydratase (Enolase)IBA
02/2011 - 11/2009
3InterleukinsIBA
01/2011 - 03/2003
3vinorelbine (Navelbine)FDA LinkGeneric
11/2009 - 09/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 11/2004
3Apolipoproteins B (ApoB)IBA
03/2008 - 08/2002
3gefitinib (Iressa)FDA Link
02/2008 - 12/2005
3gemcitabineFDA Link
02/2008 - 01/2003
3ChemokinesIBA
01/2007 - 01/2003
3olmesartanIBA
01/2006 - 04/2004
3Histamine (Histamine Dihydrochloride)FDA Link
11/2002 - 03/2002
2tiotropium (Spiriva)FDA Link
01/2015 - 01/2012
2Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
09/2014 - 03/2011
2AntigensIBA
01/2014 - 04/2012
2montelukast (Singulair)FDA Link
08/2012 - 03/2002
2AllergensIBA
01/2012 - 06/2007
2amrubicinIBA
09/2011 - 01/2009
2big gastrinIBA
02/2011 - 02/2010
2thymidine 5'-triphosphate (TTP)IBA
02/2010 - 11/2009
2Chemokine CCL5IBA
01/2010 - 11/2006
2oxidized low density lipoproteinIBA
10/2008 - 06/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2008 - 01/2008
2LDL CholesterolIBA
08/2008 - 08/2002
2Apolipoprotein B-48IBA
08/2008 - 03/2008
2Messenger RNA (mRNA)IBA
12/2007 - 05/2003
2LigandsIBA
09/2007 - 11/2006
2Toll-Like Receptors (Toll-Like Receptor)IBA
09/2007 - 01/2007
2ciclesonideFDA Link
07/2007 - 07/2007
2Chemokine CX3CL1IBA
11/2006 - 06/2005
2V28 receptorIBA
11/2006 - 06/2005
2GTP-Binding Proteins (G-Protein)IBA
06/2006 - 10/2005
2SteroidsIBA
03/2006 - 11/2002
2Interleukin-6 (Interleukin 6)IBA
09/2005 - 03/2003

Therapy/Procedure

11Drug Therapy (Chemotherapy)
09/2011 - 08/2004
3Radiotherapy
11/2009 - 01/2009
3Renal Dialysis (Hemodialysis)
03/2008 - 06/2003
3Aftercare (After-Treatment)
02/2008 - 05/2003
3Continuous Positive Airway Pressure
12/2004 - 03/2003
2Injections
12/2006 - 09/2006